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Yeast becomes a cell biologist
 
ummer research collaborations at the Woods Hole Marine
Biological Laboratory have a magical way of unveiling cellular
secrets. In 1982, when Alison Adams, her graduate advisor
John Pringle, and John Kilmartin met up, little did they know that their
attempts to visualize actin and tubulin would transform yeast from a
genetics-only organism to a cell biology workhorse.
For her graduate work, Adams wanted to study what actin was
doing in yeast, specifically using immunofluorescence (IF) for local-
ization. But her committee members (and many others in the field)
were skeptical, because the impermeable yeast cell wall would block
antibody penetration. Pringle says he distinctly remembers “having
pessimistic conversations” about small, round yeast cells making bad
candidates for IF compared with the large, flattened cells that were in
vogue for the technique.
The two went to Woods Hole to see if Bob and Anne Goldman’s
antibodies to mammalian cytoskeletal proteins would recognize yeast
proteins. By chance, Kilmartin was there with his new monoclonal anti-
tubulin antibody, which he had already managed to get into sphero-
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plasts. The spheroplasts showed good IF, but had lost the original cell’s shape and organization. “We
decided to try to fix the cells before removing the cell wall,” Adams recalls. It worked. “It was exciting to see
cytoplasmic microtubules in yeast that are hard to see by EM, but by IF they really stood out.”
IF tools now in hand, Adams and Pringle returned to the University of Michigan (Ann Arbor, MI), and Kilmartin
to the MRC Laboratory of Molecular Biology (Cambridge, UK) to delve further into the roles of actin and micro-
tubules. Kilmartin examined actin by IF while Adams stained it with the newly available fluorescent phalloidin.
In two papers, they described the distribution of actin in cortical patches and cytoplasmic cables that
ran along the long axis of mother–bud pairs (Adams and Pringle, 1984; Kilmartin and Adams, 1984), a
phenomenon particularly clear in mutants with elongated buds. The studies also revealed that the IF patterns
of actin and tubulin never significantly overlapped during the cell cycle. And actin was seen
around the base of small, forming buds and clustered in the neck region during cytokinesis.
This last observation suggested that maybe the neck-localized actin was driving the new
cell wall growth of bud formation—a distinct switch from the prevailing view that microtubules
served this function. A few years later, this idea was solidified when Peter Novick and David
Botstein showed that temperature-sensitive actin mutants were defective for polarized secretion
to the bud (Novick and Botstein, 1985). The Botstein and Pringle labs also showed bud growth
occurring normally in the absence of microtubules (Huffaker et al., 1988; Jacobs et al., 1988).
As for the actin patches, they are now thought to act as endosome coats (Huckaba et al., 2004).
The studies’ biggest contribution—IF of internal yeast structures—got only a brief mention.
“Effective IF procedures for yeasts,” the authors noted, “should greatly facilitate use of these
genetically tractable organisms for study of various problems in cell biology.” Adams says she did not
appreciate the full potential of the technique at the time. “We didn’t even have a fluorescence scope in the lab,”
she says. “I had to hike 20 minutes over to the medical school and call back to John to describe what I was seeing.”
When the findings were presented at the 1983 yeast meeting, however, there was a palpable buzz
from interested colleagues. David Drubin, whose current studies of yeast actin draw heavily on real-time
fluorescence microscopy, says he remembers the impact the breakthrough made on his choice of post-doctoral
positions. “People tended to think of yeast as a big bacterium—you couldn’t use it for questions of spatial
organization,” he says. “Now, you could have really powerful genetics and see how the structures in a cell
changed. It just opened up for yeast.” 
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More than one way to attach
 
ow cells connect to each other and
to the extracellular matrix (ECM)
was a sticky issue in the early
1980s. Integrins, molecules that hook the cy-
toskeleton to ECM proteins such as collagen
and fibronectin, hadn’t been discovered, but
evidence for a link between external and
internal fibers was mounting. For example,
Irwin Singer (1979) observed that extra-
cellular fibronectin molecules closely
approached—or possibly attached to—
intracellular actin. Several researchers pos-
tulated that membrane-spanning receptors
made the connection. A pair of papers by
post-doc Wen-Tien Chen of the University
of California, San Diego, and his adviser S.
H
 
Jonathan Singer bolstered the idea that cells
deploy different membrane receptors to cou-
ple with different components of the matrix.
A new technique devised in Singer’s
lab gave the researchers a clearer look at
the junction between cell and surface. They
reared cells on a gelatin mat, which they
could roll up like a carpet, freeze, and cut
into thin slices. Staining the gap with two
types of antibodies pinpointed proteins
clustering on both sides of the membrane.
When the researchers zoomed in on a type
of contact called a focal adhesion, they saw
no signs of fibronectin outside the cell,
although it’s a key component of some cell
surface junctions (Chen and Singer, 1980).
Fibronectin’s absence meant that cells
needed a second kind of receptor to attach
to the extracellular fibers found in focal
adhesions, the researchers hypothesized.
A follow-up study that included more
kinds of contacts (Chen and Singer, 1982).
They found that fibronectin amassed in two
kinds of interactions, but not in two others.
Moreover, at one type of fibronectin-rich
junction, microfilaments inside the cell ran
 
Dishing up bone formation
 
iroaki Kodama knew little about dental and bone re-
search when he became an assistant professor at
Tohoku Dental University. What he 
 
did
 
 know was cell
culture technology, and he recognized the field’s need for a
clonal cell line “which retains as far as possible a normal ability
to differentiate into functional cells.”
In 1979, he and his colleagues started establishing cell lines
that differentiated into osteoblasts (bone-forming cells) rather than
odontoblasts (dentin-forming cells). At that time, only a few pri-
mary bone cell cultures had been reported to show hints of in vitro
bone formation (Binderman et al., 1979; Nijiweide et al., 1982).
Kodama (RIKEN, Wako Saitama, Japan), says the secret
to success was using the same cell culture method used to make
the immortalized mouse fibroblast 3T3 cell line (Todaro and
Green, 1963; see “A cell line that is under control” 
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 168:
988). This meant repeated subcultivation of newborn mouse
skull bone cells under 3T3 conditions—3 days to transfer at a
factor of 3 cell plating density.
When one of the lines that arose, called MC3T3-E1, be-
came confluent, it exhibited properties of osteoblasts, including
high alkaline phosphatase activity and staining for calcified se-
cretions (Sudo et al., 1983). At day 21 of culture, calcified
nodes appeared and then grew in number and size to eventually
fuse with one another. By day 30, white nodes in the dish were
visible to the naked eye. But because calcium is easily deposited
under basic culture conditions, the team had to show that they 
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parallel to the membrane. But in another
sort of interaction devoid of fibronectin,
microfilaments attached to the membrane
head-on, like an extension cord plugging
into a wall socket. These structural differ-
ences solidified the case that cells carry dif-
ferent receptors for different extracellular
matrix proteins, says Chen (now at the State
University of New York, Stony Brook).
One type fastens fibronectin to microfila-
ments stretching along the membrane; the
other joins other extracellular proteins to
microfilaments that arrive perpendicular to
the membrane. Chen then teamed with
Kenneth Yamada of the National Cancer
Institute to characterize a fibronectin-grab-
bing receptor (Chen et al., 1985), which
later work identified as an integrin. 
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Different cell adhesion sites have different 
arrangements of vinculin (V) and fibronectin (F).
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were seeing true bone formation.
Mineralization proceeded in
much the same way it did in vivo,
by the secretion of matrix vesicles
containing crystals, which were de-
posited along collagen fibrils. Elec-
tron diffraction defined the crystals
as hydroxyapatite, the chemical
that forms bone matrix.
But in vitro bone formation,
Kodama notes, was not easily repro-
ducible by other groups until the dis-
covery that bone morphogenetic
protein acts as a potent inducer of
osteoblast differentiation (Yamaguchi
Making bone in a dish: osteo-
blasts (Ob) surround a nodule 
of young osteoclasts (YOc) em-
bedded in mineralized matrix.
K
O
D
A
M
A
 
et al., 1991). The MC3T3 cell line remains an important tool
for studying bone cell differentiation today, with renewed focus
on mesenchymal stem cell differentiation and the need for better
osteoporosis therapies, like bone-building agents. In fact, the
line was the most widely distributed by the RIKEN Bioresource
Center (Tsukuba, Japan) in 2003. 
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